FDA’s caution to physicians about autism-Tylenol link fuels debate
HQ Team September 23, 2025: The U.S. Food and Drug Administration (FDA) has recently issued a cautionary note regarding the use of acetaminophen.
Drugs
Health
Drugs
Health
Pharma
A third of blood cancer cases in J&J trials live without detectable cancer
HQ Team June 4, 2025: A third of patients with a type of blood cancer, especially those whose disease had returned or not.
Drugs
Health
Pharma
Amplifica’s human trial medicine for hair growth shows 15% more efficacy
Amplifica Holdings Group Inc.’s first-in-human trial of an injectable medicine for treating hair loss has shown a more than 15% increase in non-vellus.
Drugs
Health
Pharma
Indian drug body alerts public to 52 spurious medicines in market
HQ Team September 27, 2024: The Central Drugs Standard Control Organisation (CDSCO) of India recently issued a notification regarding identifying 52 spurious drugs.
Drugs
Health
Pharma
Neurocine’s mid-stage trial drug cuts schizophrenia severity symptoms
US-based Neurocrine Biosciences’ trial drug for treating schizophrenia reduced the severity of the disease symptoms in a mid-stage study of 210 adult participants.
Drugs
Health
Pharma
FDA gives nod for AstraZeneca’s Imfinzi to treat endometrial cancer
The US Food and Drug Administration has approved AstraZeneca’s combination therapy, Imfinzi, for adult patients with endometrial cancer, according to a company statement.
Drugs
Health
Pharma
Pfizer says trials on lymphoma drug ‘positive,’ extends life of patients
HQ Team March 12, 2024: Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded.
Drugs
Health
Pharma
Eli Lilly’s drug gets second FDA nod for treating blood cancer in adults
HQ Team December 4, 2023: Eli Lilly and Company got a second accelerated approval from the Food and Drug Administration for its blood.